Collaborative Drug Therapy Management by Pharmacists - 2003

American College of Clinical Pharmacy, Raymond W. Hammond, PharmD, FCCP, Amy H. Schwartz, PharmD, Marla J. Campbell, PharmD, Tami L. Remington, PharmD, Susan Chuck, PharmD, Melissa M. Blair, PharmD, Ann M. Vassey, PharmD, Raylene M. Rospond, PharmD, FCCP, Sheryl J. Herner, PharmD, and C. Edwin Webb, PharmD, MPH

Disclosures

Pharmacotherapy. 2003;23(9) 

In This Article

Introduction

The American College of Clinical Pharmacy (ACCP) published its initial position statement on collaborative drug therapy management by pharmacists in 1997.[1] Since that time both the public and the evolving health care delivery system have become increasingly aware of both the benefits and risks posed by the growing role of pharmacotherapy in patient care. In that same period, more than 250 new drugs were approved by the Food and Drug Administration,[2] the Institute of Medicine released two important reports on the issues of preventable errors and needed changes in health care systems,[3,4] and expenditures for drugs increased an average of 17%/year -- among the highest increases for any component of health care.[5] Clearly, drug therapy has become one of the cornerstones of modern health care delivery. Consequently, effective and rational management of increasingly complex drug therapies is now essential both to the health and welfare of patients and to the efficient economic performance of health care systems and organizations of all types.

Because of their knowledge and skills in drug therapy and their accessibility to patients, pharmacists with the requisite clinical training and professional education are positioned to help patients, other health care professionals, and the health care system achieve more effective and efficient drug therapy outcomes. In recognition of this valuable role, more than 75% of states have enacted legislation or made changes in state medical and pharmacy practice acts that provide for an increased level of pharmacist involvement in the collaborative management of patients' drug therapy. The attributes of state and federal acts and regulations are summarized in Table 1 .

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....